Ampersand Biomedicines, a Flagship Pioneering multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced new preclinical ...

Results strongly support continued development of Cytoki's oral IL-22 program for UC which is part of its growing preclinical pipeline of IL-22-based assets SØBORG, Denmark, May 8, 2025 /PRNewswire/ - ...

Inflammatory bowel disease (IBD), which causes inflammation in the digestive tract, may complicate other health concerns as patients age. To address the specific challenges faced by older adults with ...

It can be overwhelming to receive a diagnosis of inflammatory bowel disease (IBD), a condition which refers to the chronic diseases that can cause inflammation in your gastrointestinal (GI) tract.